Search Results - "Burger, Maximilian"

Ensuring methodological rigor in pelvic floor muscle training research after Radical prostatectomy.

Authors: May, Matthias Wolff, Ingmar Burger, Maximilian et al.

Source: Aging Male. Dec2025, Vol. 28 Issue 1, p1-4.

Diagnostic Performance and Clinical Utility of the Uromonitor ® Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-Analysis.

Authors: Rodas Garzaro, Julio Ruben Kravchuk, Anton Burger, Maximilian et al.

Source: Diagnostics (2075-4418). Jan2026, Vol. 16 Issue 2, p285. 16p.

GPS1 Exon 9 Mutations Represent a Rare Genetic Event in Penile Squamous Cell Carcinoma Pathogenesis.

Authors: Tögel, Lars Elsner, Felix Wendler, Olaf et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 5, p2460. 14p.

Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance Evaluation.

Authors: Rinderknecht, Emily Engelmann, Simon U Saberi, Veronika et al.

Source: Journal of Medical Internet Research; 2025, Vol. 27, p1-13, 13p

Author Index: International Journal of Urology 2007.

Source: International Journal of Urology. Dec2007, Vol. 14 Issue 12, p1127-1136. 10p.

Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative Study.

Authors: Rinderknecht, Emily von Winning, Dominik Kravchuk, Anton et al.

Source: Current Oncology. Nov2024, Vol. 31 Issue 11, p7061-7073. 13p.

Leveraging Large Language Models for High-Quality Lay Summaries: Efficacy of ChatGPT-4 with Custom Prompts in a Consecutive Series of Prostate Cancer Manuscripts.

Authors: Rinderknecht, Emily Schmelzer, Anna Kravchuk, Anton et al.

Source: Current Oncology. Feb2025, Vol. 32 Issue 2, p102. 11p.

Pitfalls of monetizing relational values in the context of climate change adaptation.

Authors: Nilgen, Marco Burger, Maximilian Nicolaus Steimanis, Ivo et al.

Source: Ecosystems & People. Dec2024, Vol. 20 Issue 1, p1-19. 19p.

Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma—No Evidence for a Role in Carcinogenesis.

Authors: Fiegl, August Wendler, Olaf Giedl, Johannes et al.

Source: Current Oncology. Oct2024, Vol. 31 Issue 10, p5752-5761. 10p.

Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor.

Authors: Haas, Maximilian Kriegmair, Maximilian C. Breyer, Johannes et al.

Source: BJU International. Nov2024, Vol. 134 Issue 5, p755-762. 8p.

Nebennierentumoren: Diagnostik, perioperatives Management und operative Therapie.

Alternate Title: Adrenal tumors: diagnostics, perioperative management and surgical treatment.

Authors: Engelmann, Simon Burger, Maximilian Mayr, Roman

Source: Best Practice Onkologie. Jul2023, Vol. 18 Issue 7/8, p332-339. 8p.

Randomised controlled feasibility trial of retroperitoneal vs transperitoneal robot‐assisted partial nephrectomy: the ROPARN study.

Authors: Kälble, Sebastian Engelmann, Simon U. Schrutz, Hannah et al.

Source: BJU International. Jun2025, Vol. 135 Issue 6, p977-986. 10p.

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.

Authors: Claps, Francesco van de Kamp, Maaike W. Mayr, Roman et al.

Source: BJU International. Aug2023, Vol. 132 Issue 2, p170-180. 11p.

Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.

Authors: Denzinger, Stefan Burger, Maximilian Fritsche, Hans-Martin et al.

Source: Scandinavian Journal of Urology & Nephrology. Sep2009, Vol. 43 Issue 4, p282-287. 6p. 1 Color Photograph, 2 Charts, 2 Graphs.

Urine-Based Biomarker Test Uromonitor ® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer—A Systematic Review and Meta-Analysis of Diagnostic Test Performance.

Authors: Kravchuk, Anton P. Wolff, Ingmar Gilfrich, Christian et al.

Source: Cancers. Feb2024, Vol. 16 Issue 4, p753. 15p.

Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.

Authors: Burger, Maximilian Nicolaus Mayer, Matthias Steimanis, Ivo

Source: PLoS ONE. 6/28/2022, Vol. 17 Issue 6, p1-23. 23p.

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial).

Authors: Breyer, Johannes Eckstein, Markus Sikic, Danijel et al.

Source: Scientific Reports. 11/20/2023, Vol. 13 Issue 1, p1-10. 10p.

Impact of sarcopenia and fat distribution on outcomes in penile cancer.

Authors: Hartmann, Valerie Engelmann, Simon Udo Pickl, Christoph et al.

Source: Scientific Reports. 10/25/2024, Vol. 14 Issue 1, p1-10. 10p.

A novel grading approach predicts worse outcomes in stage pT1 non‐muscle‐invasive bladder cancer.

Authors: Haas, Maximilian Engelmann, Simon U. Mayr, Roman et al.

Source: BJU International. Aug2024, Vol. 134 Issue 2, p249-257. 9p.

Patient's Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatectomy: Differences between Certified Prostate Cancer Centers and Non-Certified Centers Based on Patient-Reported Outcomes within the Cross-Sectional Study Improve

Authors: Wolff, Ingmar Burchardt, Martin Peter, Julia et al.

Source: Cancers. May2023, Vol. 15 Issue 10, p2830. 14p.